Valenta, Sabine
Spirig, Rebecca
Miaskowski, Christine
Zaugg, Kathrin
Spichiger, Elisabeth http://orcid.org/0000-0002-6875-2650
Funding for this research was provided by:
Nursing Science Foundation Switzerland
Domarena Foundation
Foundation to combat cancer
Cantonal cancer leagues Basel and Zurich
Giuliana and Giorgio Stefanini Foundation
Article History
Received: 21 March 2017
Accepted: 19 November 2018
First Online: 12 December 2018
Ethics approval and consent to participate
: The PEINCA study was approved by the ethics committees of Basel, Bern and Zurich (EKNZ BASEC 2015–00012). The study has been recorded in Clinical Trials.gov site with the code NCT02713919, is performed in accordance with the study protocol, the Declaration of Helsinki, the Good Clinical Practice Guidelines (ICH-GCP), national legal and regulatory requirements and respect the basic ethical principles of autonomy, beneficence, non-maleficence and distributive justice. Participation of patients and FCs is entirely voluntary. After comprehensive oral and written information, the RA obtains written informed consent from all study participants. Permission was obtained from the participating University Hospitals to access patient data for the medical record review form.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.